Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Learn more PT-141 is a revolutionary peptide that has garnered attention for its potential to enhance sexual desire and function
Metabolic Pharmaceuticals terminated development for obesity in February 2007
It is a sterile and non-pyrogenic product that acts as a vehicle for hormones, antibiotics, and vaccines, among others
Why Standard Weight Loss Peptides Are Not Always Enough Appetite regulation is only one component of sustainable weight management
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Light exposure also accelerates degradation, so store vials in a dark location or wrap them in aluminum foil
US$ 21.39
US$ 21.48
US$ 22.32
US$ 29.77
US$ 21.58
US$ 23.99
US$ 27.07
US$ 21.18
